wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33416342-20BCE1AC-17FA-4208-B854-CD92A979E10E
Q33416342-20BCE1AC-17FA-4208-B854-CD92A979E10E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416342-20BCE1AC-17FA-4208-B854-CD92A979E10E
Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours.
P2860
Q33416342-20BCE1AC-17FA-4208-B854-CD92A979E10E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416342-20BCE1AC-17FA-4208-B854-CD92A979E10E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
04793ef08cf7cee6a9fa8481b37557edb93d6125
P2860
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.